Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L N Prakhova

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 7, 2009
[Neuromyelitis optica: problems of heterogeneity and systematization]N A Totolian, L N Prakhova, L Iu Sofienko, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|February 1, 2017
[Neuroprotection therapy of multiple sclerosis with high doses of ethylmethylhydroxypyridine succinate]L N Prakhova, A G Ilves, Zh I Savintceva, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 7, 2009
[Brain atrophy and neurological impairment in patients with multiple sclerosis]L N Prakhova, A G Il'ves, A M Petrov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 17, 2015
[Cortical atrophy in multiple sclerosis]L N Prakhova, A G Il'ves, E P Magonov, et al.
Neuroscience and Behavioral Physiology|December 18, 2008
Characteristics of neurological and cognitive status in patients with multiple sclerosis in relation to the location and volumes of demyelination foci and the severity of brain atrophyK K Mineev, L N Prakhova, A G Il'ves, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 14, 2012
[Current possibilities of the comprehensive diagnostic assessment in the differential diagnosis of inflammation and tumors of the spine cord]L N Prakhova, Zh I Savintseva, A F Gurchin, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 19, 2006
[Clinical and radiological (PET, MRI) correlations depending on disease progression in patients with multiple sclerosis]A G Il'ves, L N Prakhova, G V Kataeva, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 14, 2012
[Intrathecal immunoglobulin production in the diagnosis and differential diagnosis of multiple sclerosis]N A Totolian, A A Gotovchikov, S V Lapin, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|September 16, 2011
[Symptomatic epilepsy in inflammatory demyelinating diseases]N A Totolian, E V Borisova, A A Totolian, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 15, 2020
[Results of a phase 1 clinical study of anti-CD20 monoclonal antibody (BCD-132): pharmacokinetics, pharmacodynamics and safety]O V Boyko, A N Boyko, P A Yakovlev, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 7, 2009
[Neuromyelitis optica: problems of heterogeneity and systematization]N A Totolian, L N Prakhova, L Iu Sofienko, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|February 1, 2017
[Neuroprotection therapy of multiple sclerosis with high doses of ethylmethylhydroxypyridine succinate]L N Prakhova, A G Ilves, Zh I Savintceva, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 7, 2009
[Brain atrophy and neurological impairment in patients with multiple sclerosis]L N Prakhova, A G Il'ves, A M Petrov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 17, 2015
[Cortical atrophy in multiple sclerosis]L N Prakhova, A G Il'ves, E P Magonov, et al.
Neuroscience and Behavioral Physiology|December 18, 2008
Characteristics of neurological and cognitive status in patients with multiple sclerosis in relation to the location and volumes of demyelination foci and the severity of brain atrophyK K Mineev, L N Prakhova, A G Il'ves, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 14, 2012
[Current possibilities of the comprehensive diagnostic assessment in the differential diagnosis of inflammation and tumors of the spine cord]L N Prakhova, Zh I Savintseva, A F Gurchin, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 19, 2006
[Clinical and radiological (PET, MRI) correlations depending on disease progression in patients with multiple sclerosis]A G Il'ves, L N Prakhova, G V Kataeva, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 14, 2012
[Intrathecal immunoglobulin production in the diagnosis and differential diagnosis of multiple sclerosis]N A Totolian, A A Gotovchikov, S V Lapin, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|September 16, 2011
[Symptomatic epilepsy in inflammatory demyelinating diseases]N A Totolian, E V Borisova, A A Totolian, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 15, 2020
[Results of a phase 1 clinical study of anti-CD20 monoclonal antibody (BCD-132): pharmacokinetics, pharmacodynamics and safety]O V Boyko, A N Boyko, P A Yakovlev, et al.
Pageof 3